XORTX Therapeutics Inc. XRTX
XRTX
XORTX Therapeutics Inc. GLMD
Galmed Pharmaceuticals Ltd. CERO
CERo Therapeutics Holdings, Inc. ARTL
Artelo Biosciences, Inc. OCEA
Ocean Biomedical, Inc. CMMB
Chemomab Therapeutics Ltd. BIVI
BioVie Inc. MLEC
Moolec Science S.A. LIMN
Liminatus Pharma, Inc. Class A Common Stock PTIX
Protagenic Therapeutics, Inc.
XORTX Therapeutics Inc. GLMD
Galmed Pharmaceuticals Ltd. CERO
CERo Therapeutics Holdings, Inc. ARTL
Artelo Biosciences, Inc. OCEA
Ocean Biomedical, Inc. CMMB
Chemomab Therapeutics Ltd. BIVI
BioVie Inc. MLEC
Moolec Science S.A. LIMN
Liminatus Pharma, Inc. Class A Common Stock PTIX
Protagenic Therapeutics, Inc.
Performance
| Periode | XRTX | GLMD | CERO | ARTL | OCEA | CMMB | BIVI | MLEC | LIMN | PTIX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -10.34 % | 2.17 % | -80.79 % | -29.90 % | -98.55 % | -26.79 % | -78.00 % | -89.94 % | -75.45 % | -9.23 % |
| YTD | -27.35 % | -57.53 % | -98.06 % | -38.69 % | -99.90 % | -61.50 % | -91.51 % | -91.72 % | -75.45 % | -58.05 % |
| 1Y | -53.30 % | -59.25 % | -98.65 % | -43.84 % | -99.94 % | -35.94 % | -83.48 % | -92.36 % | -75.45 % | -59.66 % |
| 3Y | -89.51 % | -97.85 % | -99.99 % | -79.44 % | -99.99 % | -59.61 % | -99.32 % | -93.27 % | -75.45 % | -90.92 % |
| 5Y | -96.99 % | -99.76 % | -99.99 % | -92.89 % | -99.99 % | -95.50 % | -99.81 % | -93.07 % | -75.45 % | -97.59 % |
| 10Y | -96.99 % | -99.92 % | -99.99 % | -99.04 % | -99.99 % | -99.53 % | -98.77 % | -93.07 % | -75.45 % | -97.59 % |
| Depuis le début | -96.99 % | -99.95 % | -99.99 % | -99.04 % | -99.99 % | -99.53 % | -99.51 % | -93.07 % | -75.45 % | -97.59 % |